← Browse by Condition
Medical Condition

digital health

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 2, Phase 3

ClinicalMetric tracks all active clinical trials for digital health sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — digital health Clinical Trials

How many clinical trials are currently recruiting for digital health?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for digital health, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for digital health?
digital health research spans Phase 2 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a digital health clinical trial?
Eligibility criteria for digital health trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Phase 3
1
Top Sponsors
Imperial College London 1 trial
University of Sao Paulo General Hospital 1 trial
Istanbul Galata University 1 trial
Nanyang Technological University 1 trial

Recruiting Clinical Trials

NCT06602609
Recruiting
Remote Cardiovascular Monitoring in Post-TAVI Patients
Enrollment
216 pts
Location
United Kingdom
Sponsor
Imperial College London
View Trial →
NCT06786819
Recruiting
Impact of a Technology Platform Based on Enhanced Recovery After(ERAS) Surgery on Length of Stay After Coronary Artery Bypass Grafting: Timely Project
Enrollment
480 pts
Location
Brazil
Sponsor
University of Sao Paulo Genera...
View Trial →
NCT06581770
Recruiting
Evaluation of Validity and Reliability of the Turkish Translation of the Digital Health Readiness Questionaire in Different Chronic Diseases
Enrollment
200 pts
Location
Turkey (Türkiye)
Sponsor
Istanbul Galata University
View Trial →
NCT07497711 Phase 2, Phase 3
Recruiting
Virtual Menstrual Pain Approaches in Females
Enrollment
145 pts
Location
Singapore
Sponsor
Nanyang Technological Universi...
View Trial →

Related Conditions

aortic valve stenosis (1) cardiac conduction disturbance (1) transcatheter aortic valve implantation (1) tavi (1) eras (1) cardiac surgery (1) cardiac surgery cabg (1) non communicable chronic diseases (1) survey and questionnaire (1) validation studies (1) pain visceral somatic or neuropathic (1) women of reproductive age (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology